Kuros Biosciences
OverviewSuggest Edit
Kuros Biosciences engages in the discovery, development, and commercialization of biopharmaceutical products for the treatment and prevention of chronic diseases internationally. Its sealants pipeline products include Neuroseal EU and US for the treatment of dural sealant cranial. The Сompany's synthetic orthobiologics pipeline products comprise MagnetOs Granules EU and MagnetOs Putty EU for the treatment of orthopedics, spinal, and dental problems; and MagnetOs Granules US and MagnetOs Putty US for the treatment of spinal fusion.
| Type | Public | |
| Founded | 2000 | |
| HQ | Schlieren, CH | Map |
| Website | kurosbio.com |
Key People/Management at Kuros Biosciences
Michael Grau
Chief Financial Officer
Joost de Bruijn
Chief Executive Officer, Director
Alistair Irvine
Chief Business Officer
Phillippe Saudan
Chief Development Officer
Pascal Longlade
Chief Medical Officer
Scott Bruder
Non-Executive Director
Kuros Biosciences Office Locations
Kuros Biosciences has offices in Schlieren, Burlington and Bilthoven
Schlieren, CH (HQ)
25 Wagistrasse
Bilthoven, NL
Professor Bronkhorstlaan 10, G 48
Burlington, MA, US
111 S Bedford St #108
Kuros Biosciences Financials and Metrics
Kuros Biosciences Revenue
Market capitalization (10-Nov-2021) | 70.5m |
Closing stock price (10-Nov-2021) | 2.2 |
Kuros Biosciences's current market capitalization is CHF70.5 m.
Kuros Biosciences Cybersecurity Score
Kuros Biosciences Environment, Social & Governance (ESG) Ratings
Kuros Biosciences Online and Social Media Presence
Kuros Biosciences's Trends
Kuros Biosciences News and Updates
October 26, 2021
Kuros Biosciences Reports Continued Increase in MagnetOs U.S. Sales
Ad hoc announcement pursuant to Article 53 of the SIX listing rules Ad hoc announcement pursuant to Article 53 of the SIX listing rules
September 28, 2021
Kuros Biosciences to Showcase New MagnetOs Products at NASS 2021 Annual Meeting
SCHLIEREN (ZURICH), Switzerland, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Kuros Biosciences (“Kuros” or the “Company”), a leader in next generation bone graft technologies, announced today that it will showcase new products in the MagnetOs range at the 36th Annual Meeting of the North American Spine Soc…
March 10, 2021
Kuros Biosciences to Present at Upcoming Clinical and Investor Conferences
SCHLIEREN (ZURICH), Switzerland, March 10, 2021 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX: KURN), a leader in next generation bone graft technologies and a pioneer in the emerging field of osteoimmunology, today announced that the company will present at two major European conferences in March, b…
March 02, 2021
Kuros Biosciences Announces MagnetOs Sales and Distribution Agreements Across Northern Europe
SCHLIEREN (ZURICH), Switzerland, March 02, 2021 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX: KURN) today announced that it has signed sales and distribution agreements for MagnetOs bone graft, covering the Netherlands, Switzerland, Austria, and Finland. These add to an existing agreement in the Un…
September 01, 2020
Kuros Biosciences Announces Treatment of the First Patient in its Spinal Fusion Trial with Fibrin-PTH
SCHLIEREN (ZURICH), Switzerland, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Kuros Biosciences, a leader in next generation bone graft technologies, today announced that the first patient has been treated in the STRUCTURE trial, investigating Fibrin-PTH (KUR-113) for transforaminal lumbar interbody fusion …
Kuros Biosciences Frequently Asked Questions
When was Kuros Biosciences founded?
Kuros Biosciences was founded in 2000.
Who are Kuros Biosciences key executives?
Kuros Biosciences's key executives are Michael Grau, Joost de Bruijn and Alistair Irvine.
How many employees does Kuros Biosciences have?
Kuros Biosciences has 46 employees.
Who are Kuros Biosciences competitors?
Competitors of Kuros Biosciences include Dermavant Sciences, Biosearch Life and Alnylam Pharmaceuticals.
Where is Kuros Biosciences headquarters?
Kuros Biosciences headquarters is located at 25 Wagistrasse, Schlieren.
Where are Kuros Biosciences offices?
Kuros Biosciences has offices in Schlieren, Burlington and Bilthoven.
How many offices does Kuros Biosciences have?
Kuros Biosciences has 3 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies